Naomi de Silva

Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade

D. McDonald, N. de Silva, Mitsuko Inoue, 2021, Molecular therapy oncolytics.

Targeting tumor vasculature with an oncolytic virus.

H. Atkins, A. Fenster, D. Kirn, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.

R. Patt, D. Kirn, S. Thorne, 2013, Cancer research.

Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms.

D. McDonald, D. Kirn, C. Breitbach, 2018, Cancer research.

VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection.

H. Atkins, J. Diallo, D. Kirn, 2015, Cancer cell.